Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds
about
Novel C,N-chelate rhodium(III) and iridium(III) antitumor complexes incorporating a lipophilic steroidal conjugate and their interaction with DNA.BODIPY-phosphane as a versatile tool for easy access to new metal-based theranostics.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexesTowards the elaboration of new gold-based optical theranostics.Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.Cytotoxicity, apoptosis, cell cycle arrest, reactive oxygen species, mitochondrial membrane potential, and Western blotting analysis of ruthenium(II) complexes.Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.Ruthenium(II) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules.Development of trackable metal-based drugs: new generation of therapeutic agents.NanoSIMS analysis of an isotopically labelled organometallic ruthenium(II) drug to probe its distribution and state in vitro.In vitro effects of binuclear (η (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen.
P2860
Q34415646-2ABEE415-DACA-4333-A5F2-40113081F1A6Q34509157-105F37E8-3313-4EAC-ADA0-5CB52A2B20A3Q38052406-A6FFB836-97D1-48C1-85C5-D9F7417B78E1Q38693266-A30A5C17-73C7-4BA0-B30F-2CB5340FAABAQ38930321-31CC5C3B-27C7-44DA-B942-1147CB6B618BQ38939454-E95E66D0-1D89-4EAB-B42B-F09F0F7C8954Q39103148-0115E18D-0C29-4F59-A14F-D5DAD602CB42Q39178846-9A4E8715-3523-4C57-9AEC-2B2C93795672Q39229950-702E544B-45B0-4309-86A2-400ED24716DBQ39236976-C29E6C87-3CE2-47B0-B65A-2DC7D628E0D3Q44548288-E5493A7D-F47F-475D-ABA9-9AEB6AE1FEF4Q50856412-5C726958-7F75-4197-90DF-536B8B332F33Q51700817-19BC4CB6-944F-4676-843C-20DE81B1F69CQ54168463-E3A221D6-768B-4505-9C77-FBB7C075E624
P2860
Anthracene-tethered ruthenium(II) arene complexes as tools to visualize the cellular localization of putative organometallic anticancer compounds
description
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 06 March 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Anthracene-tethered ruthenium
@nl
Anthracene-tethered ruthenium( ...... ometallic anticancer compounds
@en
type
label
Anthracene-tethered ruthenium
@nl
Anthracene-tethered ruthenium( ...... ometallic anticancer compounds
@en
prefLabel
Anthracene-tethered ruthenium
@nl
Anthracene-tethered ruthenium( ...... ometallic anticancer compounds
@en
P2093
P50
P356
P1433
P1476
Anthracene-tethered ruthenium( ...... ometallic anticancer compounds
@en
P2093
Frederic Schmitt
Julie Risse
Lucienne Juillerat-Jeanneret
Rosario Scopelitti
P304
P356
10.1021/IC202530J
P407
P50
P577
2012-03-06T00:00:00Z